P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
5,334.05
173.15 (3.36%)
BSENSE

May 06

BSE+NSE Vol: 21.97 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Standalone Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 14.38% vs 4.57% in Dec 2024

stock-summary

Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 22.26% vs 3.15% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 12.37% vs 10.85% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is -32.00% vs -3.85% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024

Compare Nine Monthly Results Of P & G Health Ltd With
Markets Mojo
Figures in Cr
Standalone Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,037.52
979.91
57.61
5.88%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,037.52
979.91
57.61
5.88%
Raw Material Cost
222.14
442.94
-220.80
-49.85%
Purchase of Finished goods
48.27
59.80
-11.53
-19.28%
(Increase) / Decrease In Stocks
1.80
0.72
1.08
150.00%
Employee Cost
171.70
89.06
82.64
92.79%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
272.54
169.81
102.73
60.50%
Total Expenditure (Excl Depreciation)
716.45
762.33
-45.88
-6.02%
Operating Profit (PBDIT) excl Other Income
321.07
217.58
103.49
47.56%
Other Income
13.34
76.06
-62.72
-82.46%
Operating Profit (PBDIT)
334.41
293.64
40.77
13.88%
Interest
0.34
0.98
-0.64
-65.31%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
334.07
292.66
41.41
14.15%
Depreciation
17.42
25.47
-8.05
-31.61%
Profit Before Tax
316.65
267.19
49.46
18.51%
Tax
84.34
58.41
25.93
44.39%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
232.31
208.77
23.54
11.28%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
232.31
208.77
23.54
11.28%
Equity Capital
16.60
45.32
-28.72
-63.37%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
0.00
0.00
0.00
Operating Profit Margin (Excl OI)
30.95%
22.20%
0.00
8.75%
Gross Profit Margin
32.20%
29.87%
0.00
2.33%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 1,037.52 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 14.38% vs 4.57% in Dec 2024

Nine Monthly - Standalone Net Profit
Standalone Net Profit 232.31 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 22.26% vs 3.15% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 321.07 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 12.37% vs 10.85% in Dec 2024

Nine Monthly - Interest
Interest 0.34 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -32.00% vs -3.85% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.95%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024